A
AZN
AstraZeneca PLC
$162.03
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of AstraZeneca PLC in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
$3.73
Yield
2.30%
EPS
$6.69
P/E
23.5
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: $2.70
Oct 30
Posts
No posts about AZN yet.
About AstraZeneca PLC
AstraZeneca is a British-Swedish drug company based in the UK. It develops and sells prescription medicines, mainly for cancer, heart and kidney disease, diabetes, and breathing problems, plus rare diseases and vaccines. It makes money by selling patented drugs to hospitals, pharmacies, and health systems around the world.